Beijing Dacheng Biotechnology Co., Ltd. was established in 2014. It is a national high-tech enterprise specializing in R&D, production, and sales of high-quality in vitro diagnostic reagent raw materials. The company is listed as a high-quality, boutique and particularly innovative enterprise in Beijing . In 2019, the company obtained the national high-tech innovation technology enterprise certificate. In 2020, the company obtained the Beijing Zhongguancun High-tech and Innovative Enterprise Certificate . Dacheng Bio's products are key raw materials for IVD (including diagnostic enzymes, polyclonal antibodies, monoclonal antibodies, special proteins, etc.). The company currently has corresponding recombinant antibodies, molecular construction, cell fermentation, protein purification, and animal immunity platforms. Dacheng Bio regards quality as life, pursues excellence and sustainable development. In 2016, the company passed the ISO9001 quality management system certification; In 2022, the company passed the ISO13485 medical device quality management system certification. Dacheng Bio is committed to manufacturing first-class in vitro diagnostic reagent raw materials and contributing to the cause of human health.